Table 4

Cox Multivariable Analysis of Overall Survival in All Primary Malignant Peripheral Nerve Sheath Tumors: Radiation Sequence and Extent of Surgery

CharacteristicDefinitionMultivariable AnalysisMultivariable Analysis
HR95% CIPHR95% CIP
Age19-59Ref.Ref.
<180.790.66-0.97.0200.800.66-0.97.023
60+1.791.60-1.99<.0011.781.59-1.98<.001
SexFemaleRef.Ref.
Male1.151.04-1.27.0081.161.05-1.28.005
RaceWhiteRef.Ref.
Black1.271.09-1.46.0021.231.06-1.42.006
Asian and other0.930.77-1.12.4320.930.77-1.12.431
Unknown0.420.14-1.32.1370.400.13-1.26.117
TherapySx only
Rx only
Sx and Rx
None
Unknown
SurgeryGTRRef.
PR1.100.96-1.27.174
Biopsy1.561.13-2.14.007
No Sx1.931.60-2.32<.001
Sx NOS1.161.00-1.35.055
Unknown1.971.53-2.52<.001
Radiation SequenceNo Sx or no RxRef.
Rx after Sx0.970.86-1.09.569
Rx before Sx0.850.67-1.09.209
Rx b/a Sx0.740.40-1.39.355
Rx intraop0.720.32-1.60.418
Unknown0.980.44-2.19.958
Tumor LocationLimbsRef.Ref.
Intracranial0.880.66-1.17.3800.740.55-1.00.046
Spinal1.230.91-1.66.1771.310.97-1.77.084
H&N1.321.11-1.58.0021.281.08-1.53.005
Core1.621.44-1.83<.0011.571.39-1.77<.001
NOS and Unknown1.991.61-2.45<.0011.731.40-2.15<.001
Tumor GradeIRef.Ref.
II1.330.94-1.88.1131.350.96-1.92.101
III2.832.02-3.96<.0012.822.02-3.95<.001
IV3.402.45-4.71<.0013.402.45-4.71<.001
Unknown2.441.79-3.34<.0012.322.32-1.69<.001
Tumor Size≤50 mmRef.Ref.
>50 mm2.332.00-2.72<.0012.331.99-2.72<.001
Unknown1.931.65-2.25<.0011.821.55-2.13<.001
CharacteristicDefinitionMultivariable AnalysisMultivariable Analysis
HR95% CIPHR95% CIP
Age19-59Ref.Ref.
<180.790.66-0.97.0200.800.66-0.97.023
60+1.791.60-1.99<.0011.781.59-1.98<.001
SexFemaleRef.Ref.
Male1.151.04-1.27.0081.161.05-1.28.005
RaceWhiteRef.Ref.
Black1.271.09-1.46.0021.231.06-1.42.006
Asian and other0.930.77-1.12.4320.930.77-1.12.431
Unknown0.420.14-1.32.1370.400.13-1.26.117
TherapySx only
Rx only
Sx and Rx
None
Unknown
SurgeryGTRRef.
PR1.100.96-1.27.174
Biopsy1.561.13-2.14.007
No Sx1.931.60-2.32<.001
Sx NOS1.161.00-1.35.055
Unknown1.971.53-2.52<.001
Radiation SequenceNo Sx or no RxRef.
Rx after Sx0.970.86-1.09.569
Rx before Sx0.850.67-1.09.209
Rx b/a Sx0.740.40-1.39.355
Rx intraop0.720.32-1.60.418
Unknown0.980.44-2.19.958
Tumor LocationLimbsRef.Ref.
Intracranial0.880.66-1.17.3800.740.55-1.00.046
Spinal1.230.91-1.66.1771.310.97-1.77.084
H&N1.321.11-1.58.0021.281.08-1.53.005
Core1.621.44-1.83<.0011.571.39-1.77<.001
NOS and Unknown1.991.61-2.45<.0011.731.40-2.15<.001
Tumor GradeIRef.Ref.
II1.330.94-1.88.1131.350.96-1.92.101
III2.832.02-3.96<.0012.822.02-3.95<.001
IV3.402.45-4.71<.0013.402.45-4.71<.001
Unknown2.441.79-3.34<.0012.322.32-1.69<.001
Tumor Size≤50 mmRef.Ref.
>50 mm2.332.00-2.72<.0012.331.99-2.72<.001
Unknown1.931.65-2.25<.0011.821.55-2.13<.001

Abbreviations: b/a, before and after; CI, confidence interval; GTR, gross total resection; H&N, head and neck; HR, hazard ratio; intraop, intraoperatively; NOS, not otherwise specified; PR, partial resection; Ref., reference; Rx, radiotherapy; Sx, surgery.

Table 4

Cox Multivariable Analysis of Overall Survival in All Primary Malignant Peripheral Nerve Sheath Tumors: Radiation Sequence and Extent of Surgery

CharacteristicDefinitionMultivariable AnalysisMultivariable Analysis
HR95% CIPHR95% CIP
Age19-59Ref.Ref.
<180.790.66-0.97.0200.800.66-0.97.023
60+1.791.60-1.99<.0011.781.59-1.98<.001
SexFemaleRef.Ref.
Male1.151.04-1.27.0081.161.05-1.28.005
RaceWhiteRef.Ref.
Black1.271.09-1.46.0021.231.06-1.42.006
Asian and other0.930.77-1.12.4320.930.77-1.12.431
Unknown0.420.14-1.32.1370.400.13-1.26.117
TherapySx only
Rx only
Sx and Rx
None
Unknown
SurgeryGTRRef.
PR1.100.96-1.27.174
Biopsy1.561.13-2.14.007
No Sx1.931.60-2.32<.001
Sx NOS1.161.00-1.35.055
Unknown1.971.53-2.52<.001
Radiation SequenceNo Sx or no RxRef.
Rx after Sx0.970.86-1.09.569
Rx before Sx0.850.67-1.09.209
Rx b/a Sx0.740.40-1.39.355
Rx intraop0.720.32-1.60.418
Unknown0.980.44-2.19.958
Tumor LocationLimbsRef.Ref.
Intracranial0.880.66-1.17.3800.740.55-1.00.046
Spinal1.230.91-1.66.1771.310.97-1.77.084
H&N1.321.11-1.58.0021.281.08-1.53.005
Core1.621.44-1.83<.0011.571.39-1.77<.001
NOS and Unknown1.991.61-2.45<.0011.731.40-2.15<.001
Tumor GradeIRef.Ref.
II1.330.94-1.88.1131.350.96-1.92.101
III2.832.02-3.96<.0012.822.02-3.95<.001
IV3.402.45-4.71<.0013.402.45-4.71<.001
Unknown2.441.79-3.34<.0012.322.32-1.69<.001
Tumor Size≤50 mmRef.Ref.
>50 mm2.332.00-2.72<.0012.331.99-2.72<.001
Unknown1.931.65-2.25<.0011.821.55-2.13<.001
CharacteristicDefinitionMultivariable AnalysisMultivariable Analysis
HR95% CIPHR95% CIP
Age19-59Ref.Ref.
<180.790.66-0.97.0200.800.66-0.97.023
60+1.791.60-1.99<.0011.781.59-1.98<.001
SexFemaleRef.Ref.
Male1.151.04-1.27.0081.161.05-1.28.005
RaceWhiteRef.Ref.
Black1.271.09-1.46.0021.231.06-1.42.006
Asian and other0.930.77-1.12.4320.930.77-1.12.431
Unknown0.420.14-1.32.1370.400.13-1.26.117
TherapySx only
Rx only
Sx and Rx
None
Unknown
SurgeryGTRRef.
PR1.100.96-1.27.174
Biopsy1.561.13-2.14.007
No Sx1.931.60-2.32<.001
Sx NOS1.161.00-1.35.055
Unknown1.971.53-2.52<.001
Radiation SequenceNo Sx or no RxRef.
Rx after Sx0.970.86-1.09.569
Rx before Sx0.850.67-1.09.209
Rx b/a Sx0.740.40-1.39.355
Rx intraop0.720.32-1.60.418
Unknown0.980.44-2.19.958
Tumor LocationLimbsRef.Ref.
Intracranial0.880.66-1.17.3800.740.55-1.00.046
Spinal1.230.91-1.66.1771.310.97-1.77.084
H&N1.321.11-1.58.0021.281.08-1.53.005
Core1.621.44-1.83<.0011.571.39-1.77<.001
NOS and Unknown1.991.61-2.45<.0011.731.40-2.15<.001
Tumor GradeIRef.Ref.
II1.330.94-1.88.1131.350.96-1.92.101
III2.832.02-3.96<.0012.822.02-3.95<.001
IV3.402.45-4.71<.0013.402.45-4.71<.001
Unknown2.441.79-3.34<.0012.322.32-1.69<.001
Tumor Size≤50 mmRef.Ref.
>50 mm2.332.00-2.72<.0012.331.99-2.72<.001
Unknown1.931.65-2.25<.0011.821.55-2.13<.001

Abbreviations: b/a, before and after; CI, confidence interval; GTR, gross total resection; H&N, head and neck; HR, hazard ratio; intraop, intraoperatively; NOS, not otherwise specified; PR, partial resection; Ref., reference; Rx, radiotherapy; Sx, surgery.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close